Author

Donovan Drouillard

Medical College of WisconsinORCID 0000-0002-2940-3511Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Donna M. McAllisteriD· 2 shared Michael B. DwinelliD· 2 shared Adriano MarcheseiD· 1 shared Elizabeth CinquegraniiD· 1 shared Francis C. PetersoniD· 1 shared Maria PoimenidouiD· 1 shared Marissa Davies· 1 shared Michael HalykoiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Donna M. McAllisterORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mutant KRAS promotes NF-kB driven CCL20 chemokine expression in pancreatic ductal adenocarcinoma

Donovan Drouillard, Marissa Davies, Donna M. McAllister, Michael B. Dwinell

This study identifies oncogenic KRAS as a driver of NF-κB-mediated CCL20 chemokine expression in pancreatic ductal adenocarcinoma and shows that targeting CCL20-CCR6 signaling can modulate immune cell recruitment.

bioRxiv · Apr 15, 2026 · PreprintCancer Biology

CXCL12 chemokine dimer signaling modulates acute myelogenous leukemia cell migration through altered receptor internalization

Donovan Drouillard, Michael Halyko, Elizabeth Cinquegrani, Maria Poimenidou, Miracle Emosİvbe, Donna M. McAllister, Francis C. Peterson, Adriano Marchese, Michael B. Dwinell

This study shows that CXCL12-LD, a dimeric variant of the chemokine, reduces chemotaxis in AML cells by altering receptor signaling and internalization, suggesting potential for improved CXCR4 targeting.

Scientific Reports · Jul 22, 2025Peer-reviewedCancer Biology